Want to see HK:6821 full AI Analyst Report?

Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821) Price & Analysis

3 Followers

6821 Stock Chart & Stats

HK$115.50

HK$2.70(2.34%)

At close: Jul 27 4:00 PM EDT

HK$115.50

HK$2.70(2.34%)

Day’s Range― - ―

52-Week RangeHK$69.20 - HK$138.70

Previous CloseN/A

Volume591.20K

Average Volume (3M)640.69K

Market Cap

HK$71.81B

Enterprise ValueHK$24.35K

Total Cash (Recent Filing)HK$7.78B

Total Debt (Recent Filing)HK$238.99M

Price to Earnings (P/E)57.0

Beta1.25

Next Earnings

Aug 24, 2026

EPS Estimate

Next Dividend Ex-DateN/A

Dividend Yield1.17%

Share Statistics

EPS (TTM)3.08

Shares Outstanding27,834,510

10 Day Avg. Volume442,016

30 Day Avg. Volume640,687

Financial Highlights & Ratios

PEG Ratio1.08

Price to Book (P/B)1.29

Price to Sales (P/S)3.40

P/FCF Ratio165.39

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

HK$132.74

Price Target Upside14.93% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)4.5

Revenue Forecast (FY)HK$9.38B

Bulls Say, Bears Say

Bulls Say

Revenue GrowthThe reported 18.8% revenue-growth metric indicates continued demand for Asymchem’s outsourced development and manufacturing services, supporting business scale and customer adoption over the medium term.

Solid ProfitabilityGross and net margins remain meaningfully positive, showing that the CDMO model can generate profitable revenue across development and manufacturing work while retaining resources for operations and investment.

Very Low LeverageExtremely low leverage limits interest and refinancing risk, giving Asymchem substantial financial flexibility to sustain facilities, support customer programs, and manage industry or project-cycle volatility.

Bears Say

Profitability Below PeakThe substantial decline from prior peak margins indicates reduced earnings power or a less favorable project mix. If normalization persists, it could constrain profit growth even as revenue expands.

Weak Free Cash Flow ConversionThin free cash flow relative to accounting earnings and negative recent FCF growth suggest that working capital or investment needs are absorbing cash, reducing internally generated funding for expansion.

Recent Revenue Growth ModerationThe recent moderation in revenue growth suggests that earlier expansion has not been fully sustained. Slower top-line progression may make it harder to offset margin normalization and maintain strong earnings growth.

Asymchem Laboratories (Tianjin) Co., Ltd. Class H News

Asymchem Completes Small Share Repurchase Under 2025 Incentive Scheme

An announcement from Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( ($HK:6821) ) is now available. Asymchem Laboratories...

16h ago

6821

Asymchem Labs Sets Board Meeting to Approve 2026 Interim Results

Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( ($HK:6821) ) has issued an update. Asymchem Laboratories (Tianjin) Co.,...

8d ago

6821

Asymchem Calls 2026 EGM to Approve New Share Schemes and Biotech Investment

Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( ($HK:6821) ) has provided an announcement. Asymchem Laboratories (Tianjin) Co.,...

19d ago

6821

Asymchem Plans 2026 H Share Restricted Scheme to Align Incentives

The latest announcement is out from Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( ($HK:6821) ). Asymchem Laboratories...

20d ago

6821

Asymchem Injects RMB1.24 Billion Into CDMO Subsidiary in Connected Deal

Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( ($HK:6821) ) has shared an announcement. Asymchem Laboratories (Tianjin) Co.,...

20d ago

6821

Asymchem Laboratories Reports Strong Turnout at 2026 Extraordinary and Class Meetings

An announcement from Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( ($HK:6821) ) is now available. Asymchem Laboratories...

1M ago

6821

Asymchem Clarifies Size of H-Share Restricted Share Grant

Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( ($HK:6821) ) just unveiled an announcement. Asymchem Laboratories (Tianjin) Co.,...

1M ago

6821

Asymchem Expands H Share Incentive Grants Without Diluting Shareholders

An update from Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( ($HK:6821) ) is now available. Asymchem Laboratories...

1M ago

6821

Asymchem Proposes 2026 A Share Incentive Scheme for Key Staff

Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( ($HK:6821) ) has provided an announcement. Asymchem Laboratories (Tianjin) Co.,...

1M ago

6821

Asymchem Aligns H Share Register Closure for Dividend and Shareholder Meetings

Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( ($HK:6821) ) has issued an announcement. Asymchem Laboratories (Tianjin) Co.,...

2M ago

6821

6821 FAQ

What was Asymchem Laboratories (Tianjin) Co., Ltd. Class H’s price range in the past 12 months?

Asymchem Laboratories (Tianjin) Co., Ltd. Class H lowest stock price was HK$69.20 and its highest was HK$138.70 in the past 12 months.

What is Asymchem Laboratories (Tianjin) Co., Ltd. Class H’s market cap?

Asymchem Laboratories (Tianjin) Co., Ltd. Class H’s market cap is HK$71.81B.

When is Asymchem Laboratories (Tianjin) Co., Ltd. Class H’s upcoming earnings report date?

Asymchem Laboratories (Tianjin) Co., Ltd. Class H’s upcoming earnings report date is Aug 24, 2026 which is in 4 days.

How were Asymchem Laboratories (Tianjin) Co., Ltd. Class H’s earnings last quarter?

Asymchem Laboratories (Tianjin) Co., Ltd. Class H released its earnings results on Apr 27, 2026. The company reported HK$0.963 earnings per share for the quarter, beating the consensus estimate of HK$0 by HK$0.963.

Is Asymchem Laboratories (Tianjin) Co., Ltd. Class H overvalued?

According to Wall Street analysts Asymchem Laboratories (Tianjin) Co., Ltd. Class H’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Asymchem Laboratories (Tianjin) Co., Ltd. Class H pay dividends?

Asymchem Laboratories (Tianjin) Co., Ltd. Class H pays a Annually dividend of HK$1.495 which represents an annual dividend yield of 1.17%. See more information on Asymchem Laboratories (Tianjin) Co., Ltd. Class H dividends here

What is Asymchem Laboratories (Tianjin) Co., Ltd. Class H’s EPS estimate?

Asymchem Laboratories (Tianjin) Co., Ltd. Class H’s EPS estimate is 0.

How many shares outstanding does Asymchem Laboratories (Tianjin) Co., Ltd. Class H have?

Asymchem Laboratories (Tianjin) Co., Ltd. Class H has 27,834,510 shares outstanding.

What happened to Asymchem Laboratories (Tianjin) Co., Ltd. Class H’s price movement after its last earnings report?

Asymchem Laboratories (Tianjin) Co., Ltd. Class H reported an EPS of HK$0.963 in its last earnings report, beating expectations of HK$0. Following the earnings report the stock price went up 5.634%.

Which hedge fund is a major shareholder of Asymchem Laboratories (Tianjin) Co., Ltd. Class H?

Currently, no hedge funds are holding shares in HK:6821

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Asymchem Laboratories (Tianjin) Co., Ltd. Class H Stock Smart Score

Neutral

Analyst Consensus

Moderate Buy

Average Price Target:
HK$132.74 (14.93% Upside)

Technicals

Fundamentals

Return on Equity

1.17%

Trailing 12-Months

Asset Growth

12.62%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Asymchem Laboratories (Tianjin) Co., Ltd. Class H

Asymchem Laboratories (Tianjin) Co., Ltd. functions as a Contract Development and Manufacturing Organization (CDMO), offering its services to clients across Mainland China and internationally. The company delivers extensive drug research, development, and manufacturing solutions specifically tailored for pharmaceutical and biotechnology enterprises. Their offerings are comprehensive, covering the entire lifecycle from early clinical stages through to full commercialization, including R&D and cGMP compliant production of advanced intermediates, active pharmaceutical ingredients (APIs), and finished formulations, alongside clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the sale and distribution of medicinal products, and active participation in pharmaceutical science and technology innovation. The company was founded in 1999 and maintains its headquarters in Tianjin, China.

Asymchem Laboratories (Tianjin) Co., Ltd. Class H (6821) Earnings & Revenues

Historic Earnings Reports

6821 Stock 12 Month Forecast

Average Price Target

HK$132.74

▲(14.93% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"69":"HK$69","102":"HK$102","135":"HK$135","85.5":"HK$85.5","118.5":"HK$118.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":134,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$134.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":132.74,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$132.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":131.48,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$131.48</span>\n  </div></div>","useHTML":true}}],"tickPositions":[69,85.5,102,118.5,135],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,111.3,113.04615384615384,114.79230769230769,116.53846153846153,118.28461538461538,120.03076923076922,121.77692307692308,123.52307692307693,125.26923076923077,127.01538461538462,128.76153846153846,130.5076923076923,132.25384615384615,{"y":134,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,111.3,112.94923076923077,114.59846153846154,116.2476923076923,117.89692307692307,119.54615384615384,121.19538461538463,122.8446153846154,124.49384615384616,126.14307692307693,127.7923076923077,129.44153846153847,131.09076923076924,{"y":132.74,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,111.3,112.85230769230769,114.40461538461538,115.95692307692308,117.50923076923077,119.06153846153846,120.61384615384614,122.16615384615383,123.71846153846153,125.27076923076922,126.82307692307691,128.3753846153846,129.9276923076923,{"y":131.48,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":100.311,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.738,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.302,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.556,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.696,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.227,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":76.934,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":75.06,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.1,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":103.96,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.327,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.8,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":111.3,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >